| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Javier Perez Freije CEO | XSTU Exchange | CH1173567111 ISIN |
| Switzerland Country | 2,291 Employees | 22 Apr 2024 Last Dividend | 3 May 2022 Last Split | - IPO Date |
Mankind Pharma Limited is a prestigious entity in the pharmaceutical sector, with a focus on developing, manufacturing, and marketing an extensive range of pharmaceutical formulations and consumer healthcare products. With its roots firmly established in 1986 in New Delhi, India, the company has expanded its reach both nationally and internationally. Mankind Pharma's commitment to health extends beyond borders, covering a wide array of therapeutic areas that include acute and chronic conditions. It prides itself on being a leading provider of a variety of healthcare solutions, catering to diverse medical needs and ensuring wellness is accessible to all.